Cannara Biotech Inc. (LOVE.V)
CAD 1.42
(-1.39%)
CAD 1.42
(-1.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 6.94 Million CAD | 201.26% |
| 2022 | 2.3 Million CAD | 174.5% |
| 2021 | -3.09 Million CAD | 77.59% |
| 2020 | -13.8 Million CAD | 0.14% |
| 2019 | -13.82 Million CAD | -474.08% |
| 2018 | -2.4 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.44 Million CAD | -263.56% |
| 2024 Q1 | 2.1 Million CAD | -54.5% |
| 2024 Q3 | 2.02 Million CAD | 158.71% |
| 2023 Q4 | 4.63 Million CAD | 58.16% |
| 2023 Q1 | 49.49 Thousand CAD | -98.06% |
| 2023 FY | 6.94 Million CAD | 201.26% |
| 2023 Q2 | -641.59 Thousand CAD | -1396.31% |
| 2023 Q3 | 2.92 Million CAD | 556.46% |
| 2022 FY | 2.3 Million CAD | 174.5% |
| 2022 Q4 | 2.55 Million CAD | 22.25% |
| 2022 Q3 | 2.08 Million CAD | 258.01% |
| 2022 Q2 | -1.32 Million CAD | -42.68% |
| 2022 Q1 | -926.51 Thousand CAD | -181.86% |
| 2021 Q2 | -862.75 Thousand CAD | 75.31% |
| 2021 Q1 | -3.49 Million CAD | 9.44% |
| 2021 Q3 | 1.69 Million CAD | 296.79% |
| 2021 Q4 | 1.13 Million CAD | -33.33% |
| 2021 FY | -3.09 Million CAD | 77.59% |
| 2020 FY | -13.8 Million CAD | 0.14% |
| 2020 Q4 | -3.85 Million CAD | -62.52% |
| 2020 Q3 | -2.37 Million CAD | 32.71% |
| 2020 Q2 | -3.52 Million CAD | -29.78% |
| 2020 Q1 | -2.71 Million CAD | 23.98% |
| 2019 Q2 | -3.87 Million CAD | -30597.46% |
| 2019 Q3 | -2.55 Million CAD | 34.14% |
| 2019 Q4 | -3.57 Million CAD | -40.04% |
| 2019 FY | -13.82 Million CAD | -474.08% |
| 2019 Q1 | -12.63 Thousand CAD | 0.0% |
| 2018 FY | -2.4 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | 334.269% |
| CanadaBis Capital Inc. | 4.44 Million CAD | -56.27% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | 492.396% |
| Delivra Health Brands Inc. | 876 Thousand CAD | -692.856% |
| Entourage Health Corp. | -46.16 Million CAD | 115.044% |
| Lifeist Wellness Inc. | -14.12 Million CAD | 149.169% |
| Medicure Inc. | -922 Thousand CAD | 853.299% |
| PharmaCielo Ltd. | -16.29 Million CAD | 142.616% |
| Rubicon Organics Inc. | -1.82 Million CAD | 480.876% |
| BioSyent Inc. | 6.46 Million CAD | -7.512% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | 596.29% |